Quality Matters | U.S. Pharmacopeia Blog

// June 09, 2022

Pharmaceutical continuous manufacturing: What drug makers need to know...

Pharmaceutical continuous manufacturing (PCM) technology has gained increased attention from industry and policymakers as one way to help expand domestic manufacturing of essential medicines

Ron Piervincenzi, Ph.D.

Supply Chain

// March 14, 2022

The medicines supply chain: Increasing visibility to strengthen preparedness ...

We are doing our part by improving visibility into the upstream medicines supply chain so that vulnerabilities can be predicted and addressed before potential disruptions occur. Our solution to aid early detection of risk factors that can lead to drug shortages is USP’s Medicine Supply Map.

Vimala Raghavendran

Global Health

// March 07, 2022

Bolstering capabilities to support the supply of quality medicines...

Strengthening the medicine supply chain is a global imperative and one to which USP has long been committed. Our efforts to help strengthen the medicine supply chain aligns directly with our mission to advance the supply of quality-assured medicines to improve the health and wellbeing of people around the world.

Emily Kaine, M.D.

Supply Chain

// June 09, 2022

Pharmaceutical continuous manufacturing: What drug makers need to know...

Pharmaceutical continuous manufacturing (PCM) technology has gained increased attention from industry and policymakers as one way to help expand domestic manufacturing of essential medicines

Ron Piervincenzi, Ph.D.

Healthcare

// March 08, 2022

mRNA Vaccines: Your Questions Answered

Thanks to the vaccines developed to fight the pandemic, mRNA, specifically mRNA vaccines, has become a topic of public interest. Non-scientists want to understand what mRNA vaccines are, how they work and whether they should trust them.

USP Staff

Supply Chain

// February 24, 2022

Advanced manufacturing technology: Reducing barriers to adoption...

We need to reduce the barriers to adoption of advanced manufacturing technology (AMT) like pharmaceutical continuous manufacturing (PCM).

Joseph Hill

Featured Videos

View All Videos

Quality Medicines for Malaria

Global Health

// May 24, 2018

Quality Medicines for Malaria

Marie Lamy with Asia Pacific Leaders Malaria Alliance discusses how one country is tackling drug resistance in order to eradicate Malaria.

Rob Anderson

Poor quality medicines and drug resistance

Global Health

// May 24, 2018

Poor quality medicines and drug resistance

Harvard professor and physician Ashish Jha describes how poor quality medicines create the perfect opportunity for superbugs.

Rob Anderson

Quality medicines and sub-Saharan Africa

Global Health

// May 24, 2018

Quality medicines and sub-Saharan Africa

Global health advocate Mirfin Moundu talks about the dangers of poor quality medicines and how they are a threat to many Africans in treating infectious diseases and non-communicable diseases.

Rob Anderson

Discover More:

I am interested in:

and:

Medicines

// June 23, 2022

How medicine quality affects antimicrobial resistance and the medicines supply chain ...

Learn how medicine quality affects antimicrobial resistance and the medicines supply chain

Amy Cadwallader

Medicines

// June 22, 2022

Avoid product recalls - Know your impurities

Impurities are any components that are not active ingredients or excipients, and that can compromise quality in a drug substance or product. Pharmaceutical impurities can be classified as organic or inorganic and include residual solvents. The presence of impurities results from manufacturing and degradation processes.

Shin Kim Stella Lau Rocky Qiu

USP Leadership

// June 07, 2022

Volunteer Spotlight: USP Beal Award winner shares perspective on making a difference ...

This spring, long-time USP volunteer Dennis Gorecki, Ph.D., became the latest recipient of USP’s signature Beal Award for outstanding contributions to public health while serving as a USP volunteer.

Jaap Venema

antimicrobial resistance and supply chain

Medicines

// May 24, 2022

Supply chain vulnerabilities exist for antimicrobial medicines: USP Medicine Supply M...

Antimicrobial resistance (AMR) is one of the top global health threats. USP's latest analysis shows both an increased risk of shortages for some types of antimicrobials and the geographic concentration of facilities with active Drug Master Files (DMFs) for antimicrobials.

Vimala Raghavendran Matthew Christian

Global Health

// May 19, 2022

Fighting maternal mortality: How standards keep new moms safe...

Millions of mothers and infants continue to die from complications associated with pregnancy and childbirth annually, with sub-Saharan Africa and Southeast Asia accounting for the most (86%) maternal deaths. Several medicines are available to treat life-threatening conditions that can develop during childbirth.